Healthpeak Properties Inc. [DOC] stock prices are down -0.09% to $22.18 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DOC shares have lost -0.45% over the last week, with a monthly amount glided 6.94%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Healthpeak Properties Inc. [NYSE: DOC] stock has seen the most recent analyst activity on May 03, 2024, when Wedbush upgraded its rating to a Outperform. Previously, Exane BNP Paribas upgraded its rating to Outperform on April 26, 2024, and elevated its price target to $21. BofA Securities upgraded its rating to a Buy and increased its price target to $25 on April 01, 2024. In a note dated January 05, 2024, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
The stock price of Healthpeak Properties Inc. [DOC] has been fluctuating between $15.24 and $22.67 over the past year. Currently, Wall Street analysts expect the stock to reach $20.05 within the next 12 months. Healthpeak Properties Inc. [NYSE: DOC] shares were valued at $22.18 at the most recent close of the market. An investor can expect a potential drop of -9.6% based on the average DOC price forecast.
Analyzing the DOC fundamentals
The Healthpeak Properties Inc. [NYSE:DOC] reported sales of 2.41B for trailing twelve months, representing a surge of 27.51%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.98.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.06 points at the first support level, and at 21.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.35, and for the 2nd resistance point, it is at 22.53.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 6.43, the price to book ratio is 1.77 and price to earnings (TTM) ratio is 47.74.
Transactions by insiders
Recent insider trading involved Hall Amy M, SVP-Leasing&Physician Strategy, that happened on Dec 08 ’23 when 4001.0 shares were sold. SVP – Controller, Becker Laurie P completed a deal on Sep 14 ’23 to sell 22322.0 shares. Meanwhile, Director BLACK ALBERT JR bought 2264.0 shares on Sep 12 ’23.
